top of page

Upcoming FDA, SAMHSA Discussion on Naloxone Access

You are invited to participate in a stakeholder call to discuss naloxone access on November 28 at 2:30pm ET. Speakers will include FDA Commissioner Dr. Robert Califf and Marta Sokolowska, FDA Deputy Director for Substance Use and Behavioral Health. Dr. Miriam Delphin-Rittmon, SAMHSA Assistant Secretary for Mental Health and Substance Use, will also participate on the call. Read more

1 view0 comments

Recent Posts

See All

SAMHSA [3/27] | In a letter to clinicians, SAMHSA wrote that xylazine is an emerging public health threat and noted that routine toxicology tests do not test for the substance. Cont.

bottom of page